Abstract
Objectives
Legislation to ban smoking in public places is currently a major area of interest across Canada. The main objectives of the study were to 1) determine the effect of the smoking ban on incidence of acute myocardial infarction, 2) determine if the new legislation altered population-based smoking prevalence, and 3) measure public support for the public smoking ban.
Methods
The city of Saskatoon initiated a public smoking ban on July 1, 2004. We retrospectively reviewed all hospital discharges for acute MI from July 2000 to June 2005. We reviewed CCHS survey information on smoking prevalence for Saskatoon, Saskatchewan and Canada from 2003 to 2005. We prospectively contacted 1,255 Saskatoon residents by telephone to determine support for the public smoking ban.
Results
The age-standardized incidence rate of acute MI fell from 176.1 (95% CI 165.3–186.8) cases per 100,000 population (July 1, 2000 to June 30, 2004) to 152.4 (95% CI 135.3–169.3) cases per 100,000 population (July 1, 2004 to June 30, 2005). Smoking prevalence in Saskatoon fell from 24.1% in 2003 (95% CI 20.4–27.7) to 18.2% in 2005 (95% CI 15.7–20.9) while smoking prevalence in Saskatchewan remained unchanged at 23.8% (95% CI 22.6–25.3) and Canada reduced from 22.9% (95% CI 22.5–23.3) to 21.3% (95% CI 20.8–21.8). Seventy-nine percent of Saskatoon residents believed the smoking ban was a good idea.
Interpretation
The public smoking ban in Saskatoon, Canada, is associated with reduced incidence rates of acute MI, lower smoking prevalence and high levels of public support.
Résumé
Objectifs
Les lois interdisant le tabagisme dans les lieux publics suscitent beaucoup d’intérêt au Canada. Notre étude visait principalement à: 1) déterminer l’effet de l’interdiction du tabagisme sur l’incidence des infarctus aigus du myocarde (IAM), 2) déterminer si les nouvelles lois ont modifié la prévalence du tabagisme dans la population et 3) mesurer l’appui à l’interdiction du tabagisme dans les lieux publics.
Méthode
La ville de Saskatoon interdit le tabagisme dans les lieux publics depuis le 1er juillet 2004. Nous avons examiné rétrospectivement toutes les sorties d’hôpitaux des patients ayant subi un IAM entre juillet 2000 et juin 2005. Nous avons examiné les données de l’Enquête sur la santé dans les collectivités canadiennes (ESCC) sur la prévalence du tabagisme à Saskatoon, en Saskatchewan et au Canada de 2003 à 2005. Prospectivement, nous avons contacté par téléphone 1 255 résidents de Saskatoon pour déterminer leur appui à l’interdiction du tabagisme dans les lieux publics.
Résultats
Le taux d’incidence des IAM, sans strate d’âges, a chuté. Il est passé de 176,1 cas pour 100 000 habitants (IC de 95 % = 165,3–186,8) du 1er juillet 2000 au 30 juin 2004 à 152,4 cas pour 100 000 habitants (IC de 95 % =135,3–169,3) du 1er juillet 2004 au 30 juin 2005. La prévalence du tabagisme à Saskatoon a également chuté, passant de 24,1 % en 2003 (IC de 95 % = 20,4–27,7) à 18,2 % en 2005 (IC de 95 % = 15,7–20,9), tandis que la prévalence du tabagisme en Saskatchewan est restée inchangée à 23,8 % (IC de 95 % = 22,6–25,3); à l’échelle du Canada, elle a diminué, passant de 22,9 % (IC de 95 % = 22,5–23,3) à 21,3 % (IC de 95 % = 20,8–21,8). Soixante-dix-neuf p. cent des résidents de Saskatoon considéraient l’interdiction du tabagisme comme une bonne idée.
Interprétation
L’interdiction du tabagisme dans les lieux publics à Saskatoon, au Canada, est associée à des taux d’incidence réduits d’IAM, à une moindre prévalence du tabagisme et à des niveaux élevés d’appui du public.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
He J, Vupputuri S, Allen K, Prerost MR, Hughes J, Whelton PK. Passive smoking and the risk of coronary heart disease—A meta-analysis of epidemiologic studies. N Engl J Med 1999;340:920–26.
Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischemic heart disease: An evaluation of the evidence. BMJ 1997;315:973–80.
Barnoya J, Glantz SA. Cardiovascular effects of second hand smoke nearly as large as smoking. Circulation 2005;111:2684–98.
Pechacek TF, Babb S. How acute and reversible are the cardiovascular risks of second hand smoke? BMJ 2004;328:980–83.
Benowitz NL. Cigarette smoking and cardiovascular disease: Pathophysiology and implications for treatment. Prog Cardiovasc Dis 2003;46:91–111.
Howard G, Thun MJ. Why is environmental tobacco smoke more strongly associated with coronary heart disease than expected? A review of potential biases and experimental data. Environ Health Perspect 1999;107(Suppl 6):853-58.
Law MR, Wald NJ. Environmental tobacco smoke and ischemic heart disease. Prog Cardiovasc Dis 2003;46:31–38.
Sargent RP, Shepard RM, Glantz SA. Reduced incidence of admissions for myocardial infarction associated with public smoking ban: Before and after study. BMJ 2004;328:977–80.
Kabat G. Effect of public smoking ban in Helena, Montana: When results look too good to be true, they probably are. BMJ 2004;328:1379; doi:10.1136/bmj.328.7452.1379-b.
Heloma A, Jaakkola MS. Four year follow-up of smoke exposure, attitudes and smoking behaviour following enactment of Finland’s national smoke free workplace law. Addiction 2003;98:1111–17.
Borland R, Chapman S, Owen N, Hill D. Effects of workplace smoking bans on cigarette consumption. Am J Public Health 1990;80:178–80.
Chapman S, Borland R, Scollo M, Brownson RC, Dominello A, Woodward S. The impact of smoke-free workplaces on declining cigarette consumption in Australia and the United States. Am J Public Health 1999;89:1018–23.
Farrely MC, Evans WN, Sfekas AE. The impact of workplace smoking bans: Results from a national survey. Tobacco Control 1999;8:272–77.
Fichtenberg CM, Glantz SA. Effect of smoke-free workplaces on smoking behaviour: Systematic review. BMJ 2002;325:1–7.
Gallus S, Zuccaro P, Colombo P, Apolone G, Pacifici R, Garattini S, et al. Effects of new smoking regulations in Italy. Ann Oncol 2006;17:346–47.
Fong GT, Hyland A, Borland R, Hammond D, Hastings G, McNeill A, et al. Reductions in tobacco smoke pollution and increases in support for smoke-free public places following the implementation of comprehensive smoke-free workplace legislation in the Republic of Ireland: Findings from the ITC Ireland/UK Survey. Tob Control 2006;15(Suppl 3):51–58.
Health Canada. Smoking in public places: Quebec, Ontario and Saskatchewan. Environics Research Group, Toronto, ON: PN5620, 2005.
Liu L, Reeder B, Shuaib A, Mazagri R. Validity of stroke diagnosis on hospital discharge records in Saskatchewan, Canada: Implications for stroke surveillance. Cerebrovascular Diseases 1999;9:224–30.
Gurney JG. Brain cancer incidence in children: Time to look beyond the trends. Med Pediatr Oncol 1999;33:110–12.
Smith MA, Freidlin B, Gloeckler Ries LA, Simon R. Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Institute 1998;90(17):1269–77.
Rothman KJ, Greenland S. Modern Epidemiology, 2nd Ed. Philadelphia, PA: Lippincott Williams and Wilkins, 1998.
Statistics Canada. Canadian Community Health Survey, cycle 2.1, 2003. Ottawa.
Statistics Canada. Canadian Community Health Survey, cycle 3.1, 2005. Ottawa.
SPSS. SPSS Version 13.0 (software). Chicago: SPSS, 2004.
World Health Organization. Combating the tobacco epidemic. World health report 1999; making a difference. Geneva: WHO, 1999;65–79.
Jamrozik K. Population strategies to prevent smoking. BMJ 2004;328:759–62.
Author information
Authors and Affiliations
Corresponding author
Additional information
Source of funding: The research for this study was supported by a grant from the Canadian Tobacco Control Research Initiative which is a partnership of the Canadian Institutes of Health Research, Health Canada, the National Cancer Institute of Canada, the Canadian Cancer Society, the Heart and Stroke Foundation and the Canadian Lung Association
Rights and permissions
About this article
Cite this article
Lemstra, M., Neudorf, C. & Opondo, J. Implications of a Public Smoking Ban. Can J Public Health 99, 62–65 (2008). https://doi.org/10.1007/BF03403743
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03403743
Keywords
- Tobacco smoke pollution
- myocardial infarction
- smoking cessation–legislation and jurisprudence
- prevalence studies